{"alopecia": 3.46, "dermatitis": 18.86, "dermatitis acneiform": 215.52, "disease progression": 4.51, "dry skin": 11.96, "ejection fraction decreased": 34.45, "folliculitis": 56.27, "maligt neoplasm progression": 25.16, "metastatic maligt melanoma": 374.23, "off label use": 2.17, "paronychia": 173.64, "product use in unapproved indication": 36.86, "product use issue": 18.26, "rash": 4.52, "skin toxicity": 84.01}